The expression of PPAR-gamma in patients of pulmonary hypertension by chronic obstructive pulmonary disease
- VernacularTitle:PPAR-γ在COPD所致的肺动脉高压患者中的表达变化
- Author:
Zhongwei YANG
;
Chengguo WANG
;
Keying XUE
- Publication Type:Journal Article
- Keywords:
PPAR gamma/ME;
Pulmonary disease;
chronic obstructive/CO;
Hypertension;
pulmonary/CO/ME;
Insulin resistance
- From:
Journal of Chinese Physician
2009;11(9):1171-1173
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the relationship among peroxisome proliferators - activated receptor gamma (PPAR-γ), pul-monary arterial systolic pressure(PASP) ,and insulin resistance in Chronic Obstructive Pulmonary Disease (COPD) patients. Methods A-mong 63 COPD patients, 30 patients with level of PASP above 40mmHg were enrolled in PAH group and other 33 patients were enrolled in COPD group. Twenty healthy medical examination subjects were enrolled in control group. The expression of PPAR-γ, mRNA was detected by real time fluorescent quantitative RT- PCR. Radioimmunoassay was used to measure the level of fasting plasma insulin (FIN). Fasting plas-ma glucose (FPG) was detected by glucose oxidase method. Results The expression of PPAR-γ mRNA was significantly decreased in PAH and COPD group, while FPG, FIN and IRI increased significantly. PAH group had more increased PASP, decreased expression of PPAR-γ and higher IRI than COPD group. Expression of PPAR-γ was negatively related to PASP and IRI. Conclusions The significantly down reg-ulated expression of PPAR-γ maybe explain the higher FPG and PASP.
